We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > HDAC inhibitor

News List

Key progress has been achieved in many clinical trials of Abexinostat. Jianghuzhiyuan/PharmaSources
June 27, 2023
How much progress has been made in the research and development of HDAC inhibitor?
OnKure, Pfizer collaborate to evaluate combination of OKI-179 and binimetinib pharmaceutical-business-review
September 27, 2020
OnKure, a leader in discovery and development of next generation histone deacetylase (HDAC) inhibitors, entered into a clinical trial collaboration and supply agreement with Pfizer to support the clinical proof of concept study for MEKTOVI (binimetinib)..
PCM-075 Demonstrates Synergy with HDAC Inhibitor in Non-Hodgkin Lymphoma Cell Lines americanpharmaceuticalreview
August 22, 2017
Trovagene announced compelling results of preclinical research of PCM-075 with a Histone deacetylase (HDAC) inhibitor in Non-Hodgkin Lymphoma (NHL) cell lines.